"Cleveland Clinic is one of the largest and most respected hospitals in the country. Our mission is to provide better care of the sick, investigation into their problems, and further education of those who serve. Learn more about our leadership, vision, values and model of healthcare. Every life deserves world class care. Call or visit our website for appointment information."

During the past decade, Cleveland Clinic Mercy Hospital conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 51 clinical trials were completed, i.e. on average, 86.4% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 30 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic Mercy Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 59 trials, followed by "SWOG Cancer Research Network" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Mercy Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 39 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator and "Eastern Cooperative Oncology Group" with 4 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Mercy Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (6 trials), "Stage IV Breast Cancer AJCC v6 and v7" (6 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (5 trials). Many other conditions were trialed in "Cleveland Clinic Mercy Hospital" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Mercy Hospital" are "Drug" (88 trials), "Other" (67 trials), "Biological" (53 trials), "Procedure" (19 trials) and "Radiation" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (44 trials), "Quality-of-Life Assessment" (23 trials), "Paclitaxel" (17 trials), "Carboplatin" (14 trials) and "Cisplatin" (14 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Mercy Hospital" are 95 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Cleveland Clinic Mercy Hospital". undefined are not yet recruiting, 21 are recruiting, 44 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Cleveland Clinic Mercy Hospital, 2 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Mercy Hospital, 4 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".